Micro-Sphere enlists German expertise to boost capsule filling capabilities

Published: 2-Oct-2017

Harro Höfliger has supplied a Modu-C MS capsule filling machine that boosts Micro-Sphere’s capsule filling production

Contract development and manufacturing organisation (CDMO) Micro-Sphere has partnered with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.

The additional machine means that Micro-Sphere can achieve an average production of 72,000 capsules per hour; in addition to 100% net weight check control that ensures the correct dose is given when filling capsules for dry powder inhalers.

Micro-Sphere enlists German expertise to boost capsule filling capabilities

Micro-Sphere founder and president of the Board, Dr Michele Müller, said: “Low dose capsule filling is becoming increasingly popular across the market and at present we are the only CDMO in Europe offering this level of capability.

“Harro Höfliger’s powder expertise and technological competence is particularly evident in the Modu-C MS. This investment is an important next step in our expansion plans, allowing us to meet demand for greater capacity and speed up project delivery for our customers.”

Based in Allmersbach, Germany, Harro Höfliger develops and manufactures production and packaging systems and is a valued development partner for many pharmaceutical and medical technology companies. 

Marco Laackmann, business unit leader, inhalation at Harro Höfliger added: “The capacitive fill quantity control of the Modu-C MS offers excellent process reliability and is a great choice for Micro-Sphere in line with its continued expansion.”

From its GMP, SwissMedic and FDA approved facility near Lugano, Ticino, Micro-Sphere’s expert team supports customers in the US, Europe, New Zealand and Asia with spray drying and capsule filling capabilities for the development and manufacture of both potent and non-potent pharmaceutical products, with a particular focus on inhalable dosage forms.

You may also like